Sign in
Taking people in United StatesNo phase

Virtual group program with glucose monitors for uncontrolled type 2 diabetes

Tests group education and peer support with glucose monitors in adults with type 2 diabetes.

Key facts

Who runs it
Whole Endo
Where
Asheville, United StatesSee the site
Trial code
Registry title
Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes
Status
Recruiting
People taking part
100 people, planned
Started
1 Aug 2025
Expected to end
Aug 2028
Type of study
Observational
Treatments tested
  • Education, lifestyle counseling, and peer support
Record updated
8 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes whose blood sugar is not well controlled. They will join virtual group visits and use a continuous glucose monitor.

Age
18 years and older
Sex
All sexes can join.
Disease stage
Type 2 diabetes with uncontrolled blood sugar (hemoglobin A1c >8% (64 mmol/mol)).
Biomarker or test result
Hemoglobin A1c >8% (64 mmol/mol).

Main reasons for not taking part

  • Pregnancy
  • Use of steroids
  • Active cancer treatment
  • Terminal illness
  • Dementia or mental impairment

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Adults aged 18 years and older
  • Diagnosed with type 2 diabetes mellitus Hemoglobin A1c >8% Must have smartphone to connect with continuous glucose monitor

Who cannot take part

  • Pregnancy Use of steroids Active cancer treatment Terminal illness Dementia, mental impairment Type 1 diabetes End stage renal disease, on dialysis

Where in United States

  • Whole EndoAsheville, United StatesContact: Rashim Gupta, MDTaking people

About the trial

What the trial wants to find out

This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes. People in the study will join group visits virtually to discuss using CGM, understanding CGM, and other information about ways to bring blood sugars to your goal (nutrition, movement, reducing stress, and techniques to start a new habit).

Treatments tested

  • Education, lifestyle counseling, and peer support

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The COMPASS Program: Continuous Monitoring, Peer And Structured Support for Management of Uncontrolled Type 2 Diabetes - A Prospective Single-Arm Study
Plain-language title
Virtual group program with glucose monitors for uncontrolled type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
8 July 2025